Vanda Pharmaceuticals (VNDA) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to -$141.2 million.
- Vanda Pharmaceuticals' Profit After Tax fell 277432.82% to -$141.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$220.5 million, marking a year-over-year decrease of 106652.91%. This contributed to the annual value of -$220.5 million for FY2025, which is 106652.91% down from last year.
- According to the latest figures from Q4 2025, Vanda Pharmaceuticals' Profit After Tax is -$141.2 million, which was down 277432.82% from -$22.6 million recorded in Q3 2025.
- Vanda Pharmaceuticals' 5-year Profit After Tax high stood at $9.7 million for Q2 2021, and its period low was -$141.2 million during Q4 2025.
- In the last 5 years, Vanda Pharmaceuticals' Profit After Tax had a median value of -$1.1 million in 2023 and averaged -$9.9 million.
- Per our database at Business Quant, Vanda Pharmaceuticals' Profit After Tax soared by 167983.54% in 2021 and then tumbled by 398613.14% in 2024.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Profit After Tax stood at $7.1 million in 2021, then fell by 3.07% to $6.9 million in 2022, then tumbled by 134.98% to -$2.4 million in 2023, then tumbled by 104.67% to -$4.9 million in 2024, then tumbled by 2774.33% to -$141.2 million in 2025.
- Its last three reported values are -$141.2 million in Q4 2025, -$22.6 million for Q3 2025, and -$27.2 million during Q2 2025.